| Name | (S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone |
|---|---|
| Synonyms |
(4S)-4-[(4-AMINOPHENYL)METHYL]-2-OXAZOLIDINONE
(S)-4-(4-AMINOBENZYL)-1,3-OXAZOLIDIN-2-ONE (S)-4-(4-AMINOBENZYL)-2-OXAZOLIDINONE DIHCL (4S)-4-(4-Aminobenzyl)-1,3-oxazolidin-2-one (S)-4-[(4-Aminophenyl)-methyl]-oxazo-lidin-2(1H)-one (S)-4-(4-Aminobenzyl)-1,3-oxazolidine-2-one (S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone (4S)-4-[(4-Aminophenyl)methyl]-2-oxazolidinone MFCD03411476 (S)-4-(4-Aminobenzyl)-2-oxazolidinone,e.e (S)-4-(4-Aminobenzyl)-2(1H)-Oxazolidinone 4S)-4-(4-Aminobenzyl)-1,3-oxazolidin-2-one Zolmitriptan RC G ZolMitriptan IMpurity A (S)-4-(4-AMINO-BENZYL)-OXAZOLIDINE-2-ONE 2-Oxazolidinone, 4-[(4-aminophenyl)methyl]-, (4S) Zolmitriptan Impurity E (Zolmitriptan Related Compound G) (s)-4-(4-aminobenzyl)-1,3-oxazolidin 2-one (S)-4-(4'-AMINOBENZYL)-2-OXAZOLIDINONE Zolmitriptan Impurity 9(Zolmitriptan RC G) (S)-4-(4-Aminobenzyl)-2-oxazolidinone > (S)-4-(4'-AMINOBENZYL)-1,3-OXAZOLIDIN-2-ONE (4S)-4-[(4-aMinophenyl)Methyl]-1,3-oxazolidin-2-one (S)-4-(4-AMINOBENZYL)-2(1H)-OXAZOLIDINO& (S)-4-(4-Aminobenzyl)-2-oxazolidinone (S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone Cas 152-2 (S)-4-(4-AMINOBENZYL)-2(1H)-OXAZOLIDINONE Zolmitriptan Impurity 9(Zolmitriptan RC G)(Zolmitriptan Impurity E) (S)-4-[(4-Amino Phenyl)-Methyl]-Oxazo-lidin-2(1H)-One Zolmitriptan Related Compound G ((S)-4-(4-Aminobenzyl)oxazolidin-2-one) (S)-4-(4-AMINOBENZYL)-2-OXAZOLIDINONE (S)-4-(4-AMINOBENZYL)-1,3-OXOZOLIDIN-2-ONE (4S)-(4-AMINOBENZYL)-2-OXAZOLIDIN-2-ONE (S)-4-(4- Amido Phenyl)-1,3-Oxazolidin-2-One Zolmitriptan Imp.E : (4S)-4-[(4-aminophenyl)methyl]-1,3-oxazolidin-2-one (S)-4-(4-AMinobenzyl)-1,3-oxazoladine-2-one Zolmitriptan Impurity E (S)-4-(4- aminobenzyl)-1, 3-oxazoliden-2-one ZTR 5 Zolmitriptan Impurity E/ Zolmitriptan Related Compound G Zomitriptan impurity E Intermediate of zolmitriptan Zolmitriptan Related Compound G (S)-4-(4-AMINO-BENZYL)-OXAZOLIDIN-2-ONE (S)-4-(4-Aminobenzyl)-1,3-oxazolidine-2-oneQ: What is (S)-4-(4-Aminobenzyl)-1,3-oxazolidine-2-one Q: What is the CAS Number of (S)-4-(4-Aminobenzyl)-1,3-oxazolidine-2-one Q: What is the storage condition of (S)-4-(4-Aminobenzyl)-1,3-oxazolidine-2-one Q: What e the applications of (S)-4-(4-Aminobenzyl)-1,3-oxazolidine-2-one (S)-4-(4-AMINOBENZYL)-1,3-OXAZOLIDIN-2-ONE(FOR ZOLMITRIPTAN) |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 479.7±14.0 °C at 760 mmHg |
| Melting Point | 107-111 °C |
| Molecular Formula | C10H12N2O2 |
| Molecular Weight | 192.214 |
| Flash Point | 243.9±20.1 °C |
| Exact Mass | 192.089874 |
| PSA | 64.35000 |
| LogP | 0.52 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.600 |
| Storage condition | Room temperature. |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P301 + P312 + P330-P305 + P351 + P338 |
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R22;R36/37/38 |
| Safety Phrases | S26-S36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
|
~81%
152305-23-2 |
| Literature: Moloney, Gerard P.; Robertson, Alan D.; Martin, Graeme R.; MacLennan, Steven; Mathews, Neil; Dodsworth, Susan; Sang, Pang Yih; Knight, Cameron; Glen, Robert Journal of Medicinal Chemistry, 1997 , vol. 40, # 15 p. 2347 - 2362 |
|
~76%
152305-23-2 |
| Literature: NATCO PHARMA LIMITED; BHUJANGA RAO, Adibhatla, Kali, Satya; NANNAPANENI, Venkaiah, Chowdary Patent: WO2004/63175 A1, 2004 ; Location in patent: Page 9; 12; 14; 16-18 ; |
|
~%
152305-23-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 15 p. 2347 - 2362 |
|
~%
152305-23-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 15 p. 2347 - 2362 |
|
~%
152305-23-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 15 p. 2347 - 2362 |
|
~%
152305-23-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 40, # 15 p. 2347 - 2362 |
|
~%
152305-23-2 |
| Literature: EP1227095 A2, ; Example 1 ; |
|
~%
152305-23-2 |
| Literature: Bioorganic Chemistry, , vol. 30, # 5 p. 315 - 331 |
| Precursor 9 | |
|---|---|
| DownStream 2 | |